Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
1,76 USD | +3,53% | +10,00% | -1,77% |
Attività
Numero di dipendenti: 91
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Specialty Pharmaceutical Products
100,0
%
| 42 | 100,0 % | 40 | 100,0 % | -5,85% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
97,2
%
| 41 | 96,4 % | 38 | 97,2 % | -5,08% |
Non-United States
2,8
%
| 2 | 3,6 % | 1 | 2,8 % | -26,67% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
A. Kazimi
CEO | Chief Executive Officer | 65 | 07/01/99 |
John Hamm
DFI | Director of Finance/CFO | 67 | 01/01/19 |
James Herman
CMP | Compliance Officer | 67 | 01/01/03 |
Director/Board Member | 72 | 06/01/99 | |
Shayla Simpson
IRC | Investor Relations Contact | - | - |
Chris Bitterman
SAM | Sales & Marketing | 58 | 01/01/18 |
Kenny Acevedo
SAM | Sales & Marketing | - | 01/01/11 |
Adam Mostafa
PRN | Corporate Officer/Principal | 44 | 01/01/17 |
Tan Cheow Choon
PRN | Corporate Officer/Principal | - | - |
Todd Anthony
PRN | Corporate Officer/Principal | - | 01/01/10 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Martin Brown
BRD | Director/Board Member | 59 | 15/07/22 |
A. Kazimi
CEO | Chief Executive Officer | 65 | 07/01/99 |
Ken Krogulski
BRD | Director/Board Member | 66 | 18/01/17 |
Joseph Galante
BRD | Director/Board Member | 74 | 19/09/18 |
Director/Board Member | 72 | 06/01/99 | |
James Jones
BRD | Director/Board Member | 76 | 01/01/10 |
Caroline Young
BRD | Director/Board Member | 49 | 10/06/16 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 14 176 529 | 7 930 547 ( 55,94 %) | 0 | 55,94 % |
Coordinate società
Cumberland Pharmaceuticals, Inc.
1600 West End Avenue Suite 1300
37203, Nashville
+
http://www.cumberlandpharma.comSettore
Vendite per regione
Variaz. 1 gen. | Capi. | |
---|---|---|
-1,77% | 24,95 Mln | |
+19,62% | 43,34 Mrd | |
+20,44% | 21,96 Mrd | |
+10,86% | 14,09 Mrd | |
+13,07% | 13,64 Mrd | |
+37,46% | 11,43 Mrd | |
-8,59% | 6,86 Mrd | |
-0,05% | 6,79 Mrd | |
-8,87% | 5,73 Mrd | |
+8,46% | 5,22 Mrd |
- Borsa valori
- Azioni
- Azione CPIX
- Società Cumberland Pharmaceuticals Inc.